| |
 |
|
Class Information
Number: 514/913
Name: Drug, bio-affecting and body treating compositions > Ophthalmic > Glaucoma
Description: Subject matter wherein the ophthalmic disorder is glaucoma.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6444676 |
Use of PARP inhibitors in the treatment of glaucoma |
Sep. 3, 2002 |
| 6441047 |
Combination therapy for treating glaucoma |
Aug. 27, 2002 |
| 6426358 |
Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
Jul. 30, 2002 |
| 6423321 |
Cytokine antagonists for the treatment of sensorineural hearing loss |
Jul. 23, 2002 |
| 6419944 |
Cytokine antagonists for the treatment of localized disorders |
Jul. 16, 2002 |
| 6414021 |
Control of intraocular pressure during surgery |
Jul. 2, 2002 |
| 6403590 |
Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
Jun. 11, 2002 |
| 6387889 |
Medicinal compositions for treating eye diseases |
May. 14, 2002 |
| 6387910 |
Drug of improving optic nerve head circulation disorder |
May. 14, 2002 |
| 6384073 |
Use of macrolide compounds for treating glaucoma |
May. 7, 2002 |
| 6376541 |
Upregulation of endogenous prostaglandins to lower intraocular pressure |
Apr. 23, 2002 |
| 6359001 |
Use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes |
Mar. 19, 2002 |
| 6350467 |
Pharmaceutical preparations of glutathione and methods of administration thereof |
Feb. 26, 2002 |
| 6344485 |
Method for treating glaucoma |
Feb. 5, 2002 |
| 6342524 |
Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension |
Jan. 29, 2002 |
| 6331523 |
Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
Dec. 18, 2001 |
| 6329369 |
Methods of treating pain and other conditions |
Dec. 11, 2001 |
| 6329426 |
Method for treating ocular hypertension of glaucoma |
Dec. 11, 2001 |
| 6316443 |
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist |
Nov. 13, 2001 |
| 6316441 |
Brinzolamide and brimonidine for treating glaucoma |
Nov. 13, 2001 |
| 6300328 |
Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage |
Oct. 9, 2001 |
| 6297240 |
Method for treating ophthalmic disease through fast dispersing dosage forms |
Oct. 2, 2001 |
| 6294563 |
Combinations of prostaglandins and brimonidine or derivatives thereof |
Sep. 25, 2001 |
| 6291529 |
Alkylaminoalkyl-terminated sulfide/sulfonyl-containing propargyl amino-diol compounds for treatment of hypertension |
Sep. 18, 2001 |
| 6291506 |
Method of reducing retinal ganglion cell degeneration |
Sep. 18, 2001 |
| 6288110 |
Pharmaceutical compositions comprising disulfiram |
Sep. 11, 2001 |
| 6281208 |
Therapeutic agent for glaucoma |
Aug. 28, 2001 |
| 6274614 |
Methods, compositions and articles for reducing or preventing the effects of inflammation |
Aug. 14, 2001 |
| 6271224 |
Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
Aug. 7, 2001 |
| 6264935 |
Ophthalmic composition containing a carbonic anhydrase inhibitor and xanthan gum |
Jul. 24, 2001 |
| 6261545 |
Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders |
Jul. 17, 2001 |
| 6258844 |
Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents |
Jul. 10, 2001 |
| 6248735 |
Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist |
Jun. 19, 2001 |
| 6242442 |
Brinzolamide and brimonidine for treating ocular conditions |
Jun. 5, 2001 |
| 6232343 |
Ophthalmic preparations |
May. 15, 2001 |
| 6194415 |
Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
Feb. 27, 2001 |
| 6172054 |
Combination therapy for lowering and controlling intraocular pressure |
Jan. 9, 2001 |
| 6166073 |
Combinations of DP and FP type prostaglandins for lowering IOP |
Dec. 26, 2000 |
| 6159458 |
Sustained release ophthalmic compositions containing water soluble medicaments |
Dec. 12, 2000 |
| 6159500 |
Pharmaceutical preparations of glutathione and methods of administration thereof |
Dec. 12, 2000 |
| 6159941 |
Use of somatostatin agonists and antagonists for treating diseases related to the eye |
Dec. 12, 2000 |
| 6156785 |
Method for increasing oxygen tension in the optic nerve and retina |
Dec. 5, 2000 |
| 6136334 |
Medical uses of in situ formed gels |
Oct. 24, 2000 |
| 6127413 |
Ocular depressor |
Oct. 3, 2000 |
| 6124353 |
Method of treating ocular hypertension with 8-epi prostaglandins |
Sep. 26, 2000 |
| 6110912 |
Cytoskeletal active agents for glaucoma therapy |
Aug. 29, 2000 |
| 6107343 |
Ophthalmic and aural compositions containing diclofenac potassium |
Aug. 22, 2000 |
| 6103756 |
Ocular orally ingested composition for prevention and treatment of individuals |
Aug. 15, 2000 |
| 6090798 |
Treatment of GLC1A glaucoma with glucocorticoid antagonists |
Jul. 18, 2000 |
| 6077839 |
Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists |
Jun. 20, 2000 |
|
|
|
